Scientific Digital Imaging plc: Eastwood Park Implements ProReveal Sensitive Protein Detection Test

Published: Jul 24, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cambridge, UK: Scientific Digital Imaging’s [AIM-SDI] Synoptics Health Division, a manufacturer of innovative digital imaging systems for healthcare applications, today announced that major international healthcare training centre, Eastwood Park, UK will be using ProReveal, a test to detect proteins on surgical instruments, to complement training of sterile services professionals on how to assess the validity of decontamination processes.

The highly sensitive ProReveal in-situ fluorescence test which can detect nano- gram levels of protein will be used on decontamination courses (compliant with EU and UK guidelines), to train several hundred personnel per year from UK and international decontamination validation service providers and sterile services departments (SSDs). On the courses, they will use this technology to optimise their appreciation of cleaning efficacy within decontamination processes by detecting where and how much protein is on surgical instruments post-cleaning.

Bruce Garbutt, Training Consultant at Eastwood Park explained: “Protein decontamination currently represents the ultimate challenge in cleaning efficacy. If your process has removed protein you know your surgical instruments can be made safe to re-use. Pre 1999 we did not fully appreciate that it is possible to infect patients with prion diseases like vCJD if our cleaning processes were not optimal. More recently we have begun to realise how swab tests to detect protein levels can be flawed, hence the imperative for an ‘in situ’ test such as ProReveal. Since the CFPP 01-01 guidelines published last year highlighted that ‘in situ’ fluorescence detection of proteins is a more sensitive protein detection method, we have been planning for the future by reviewing tests to include in our decontamination courses which could comply with this new guideline.”

Garbutt added: “We were drawn to the ProReveal test because it uses OPA fluorescence detection so is more aligned with current UK and EU guidelines

After testing, we have included ProReveal in our practical demonstrations because there is a visual display of where contamination is, which aids appreciation of how instrument quality and loading configuration may affect the cleaning process. Using ProReveal we believe Authorising Engineers, for example, could be better informed during their evaluation of performance qualification tests to ensure washers are operating at their optimum. For operational staff it has the potential to be a significant advance in improving the routine verification of decontamination of surgical instruments.”

Paul Ellwood, SDI Synoptics Health’s CEO concluded: “Eastwood Park is a very progressive training centre and their adoption of the ProReveal test shows that they are preparing decontamination professionals to comply with new quality standards. Their commitment to helping professionals continuously improve their decontamination processes will ensure professionals will be able to quickly and easily implement the ProReveal technology in their own facilities, to easily meet the upcoming minimum safe residual protein contamination guideline level being set by the Department of Health. This in turn, will improve the cleanliness of reprocessed surgical instruments and more importantly, could reduce the risk of post-operative infection for thousands of patients world-wide.”

For Further Information Contact:

Jayne Arthur, Synoptics Health, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.

Tel: +44(0) 1223-727114 Fax +44 (0) 1223-727101

Email: Web site:

Bruce Garbutt, Training Consultant, Eastwood Park Training, Falfield, Wotton-under-Edge, Gloucestershire, GL12 8DA, UK.

Tel: +44 (0) 1454 262798 Fax: +44 (0) 1454 260622

Email: Web:

Editor Contact:

Dr Sue Pearson, Director, International Science Writer, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.

Tel/Fax +44 (0) 1462-635327 Email:

Web: Twitter:@isciencewriter

About Synoptics Health

Synoptics Health, based in Cambridge, UK is a division of the Synoptics Group of the AIM quoted Scientific Digital Imaging (SDI) Company based in Cambridge, UK. Synoptics is a world-leader in the development and manufacture of innovative digital imaging systems for a range of life science applications. The Group has three other divisions, Syngene, Syncroscopy and Synbiosis of which Syngene is the largest.

Syngene produces advanced systems for molecular biologists to analyse and document fluorescent DNA on gels and has systems in all the major pharmas and academic institutes world-wide. Synoptics’ other divisions Syncroscopy and Synbiosis specialise in digital imaging solutions for microscopy and microbial applications respectively. SDI’s Synoptics Group was founded in 1986 and currently employs 45 people, 20 of whom are based at Synoptics Inc. in the USA.

About Eastwood Park Training

Eastwood Park in South Gloucestershire, UK is widely acknowledged as a leading technical training centre, with an international reputation. It delivers specialist medical equipment, engineering, decontamination, facilities management and estates training, primarily to the healthcare and commercial facilities management sectors.

Most of the training offered is unique and is accredited by internationally recognised Awarding Bodies. Courses are regularly updated and new courses developed responding to new technologies, the latest official guidelines and individual sector developments.

Established over 40 years, Eastwood Park maintains its commitment to delivering quality training as much today as the day it started in this vital sector.

Help employers find you! Check out all the jobs and post your resume.

Back to news